戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s only a very minor role in the evolution of human influenza A virus.
2 ," is virucidal for H1 hemagglutinin-bearing human influenza A viruses.
3  as one mechanism for the emergence of novel human influenza A viruses.
4 the relative virulence of selected avian and human influenza A viruses.
5 cid residues that are highly conserved among human influenza A viruses.
6 e and replaced the HA gene of the prevailing human influenza A viruses.
7 otoxicity was demonstrated against avian and human influenza A viruses.
8 /20/99) or an H3 serotype (A/Panama/2007/99) human influenza A virus and then used these constructs a
9 mples of such viruses include three pandemic human influenza A viruses and canine parvovirus in dogs.
10                         The NS1A proteins of human influenza A viruses bind CPSF30, a cellular factor
11                An especially novel aspect of human influenza A virus binding is its ability to equiva
12                           The NS1 protein of human influenza A viruses binds the 30-kDa subunit of th
13                                          The human influenza A virus continues to thrive even among p
14 ts of sequencing 209 complete genomes of the human influenza A virus, encompassing a total of 2,821,1
15             Although the surface proteins of human influenza A virus evolve rapidly and continually p
16 it of the RNA polymerase complex of seasonal human influenza A viruses has been shown to localize to
17                                              Human influenza A virus (IAV) vaccination is limited by
18      Here we investigated the replication of human influenza A virus in bat cell lines and the barrie
19         Our data suggest that replication of human influenza A viruses in a nonnative host drives the
20 801) elicit robust CTL responses against any human influenza A virus, including H7N9, whereas ethnici
21  its recognition by the immune system during human influenza A virus infection.
22  the possible roles of anti-M2 antibodies in human influenza A virus infection.
23 sing the pandemic risk posed by specific non-human influenza A viruses is an important goal in public
24 y reference strain derived from the earliest human influenza A virus isolate, WS/33.
25 this residue is not conserved in a number of human influenza A virus isolates.
26 n influenza A virus hemagglutinins (HAs) and human influenza A virus matrix (M) proteins M1 and M2, w
27 esults suggest that the currently prevailing human influenza A viruses might have lost their ability
28 that phosphorylation of the NS1 protein of a human influenza A virus occurs not only at the threonine
29                                              Human influenza A viruses preferentially bind alpha2,6-l
30     To determine the role of MxA in blocking human influenza A virus replication in primate cells, we
31                   Deep sequencing of adapted human influenza A virus revealed a mutation in the PA po
32 was similar to that of a primary response to human influenza A viruses; serum neutralizing antibody w
33 ly, found in the NS1A proteins of almost all human influenza A virus strains.
34 ial cells, the primary cell type infected by human influenza A virus strains.
35 y phosphorylation of the NS1 protein of this human influenza A virus that regulates its replication i
36                               We showed that human influenza A virus uses canonical sialic acid recep
37 ne the extent of homologous recombination in human influenza A virus, we assembled a data set of 13,8

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。